AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Update

AquaBounty Technologies, Inc. (NASDAQ:AQBGet Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 67,800 shares, a decline of 14.4% from the November 15th total of 79,200 shares. Based on an average daily volume of 26,300 shares, the days-to-cover ratio is presently 2.6 days. Approximately 1.9% of the shares of the company are sold short.

AquaBounty Technologies Stock Performance

Shares of NASDAQ AQB opened at $0.57 on Monday. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.02 and a quick ratio of 2.98. The firm has a market cap of $2.21 million, a price-to-earnings ratio of -0.03 and a beta of 1.10. The stock’s fifty day moving average price is $1.04 and its two-hundred day moving average price is $1.29. AquaBounty Technologies has a one year low of $0.56 and a one year high of $3.00.

AquaBounty Technologies (NASDAQ:AQBGet Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported ($0.88) EPS for the quarter, meeting the consensus estimate of ($0.88). AquaBounty Technologies had a negative net margin of 5,842.69% and a negative return on equity of 18.20%. The business had revenue of $0.05 million for the quarter, compared to the consensus estimate of $0.10 million. During the same period in the prior year, the company posted ($1.60) earnings per share. On average, equities analysts forecast that AquaBounty Technologies will post -4.86 EPS for the current year.

AquaBounty Technologies Company Profile

(Get Free Report)

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.

See Also

Receive News & Ratings for AquaBounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AquaBounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.